Pharming Group NV (PHAR.AS)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2016||Chairman of the Board of Supervisory Directors|
|58||2008||Member of the Management Board, Chief Executive Officer|
|78||2011||Vice Chairman of the Board of Supervisory Directors|
|53||2015||Chief Financial Officer, Member of the Management Board|
|65||2006||Member of the Management Board, Chief Operations Officer|
- BRIEF-Pharming Announces FDA Acceptance For Review Of Supplemental Biologics License Application
- BRIEF-Pharming Group Announces Further Conversion Of Ordinary Convertible Bonds
- BRIEF-Pharming Group Announces Significant Conversion Of Its Ordinary Convertible Bonds
- BRIEF-Pharming Submits License Application to FDA for Ruconest
- BRIEF-Pharming Group Q3 net result swings to profit of 7.5 million euros from Q2